Akurasi Diagnostik Fibrosis Hati berdasarkan Rasio Red Cell Distribution Width (RDW) dan Jumlah Trombosit Dibanding dengan Fibroscan pada Penderita Hepatitis B Kronik

Frenky Jones, Juwita Sembiring, Lukman Hakim Zain

Abstract


Hepatitis B kronik merupakan masalah global dan Indonesia termasuk negara yang memiliki prevalensi tinggi. Keterbatasan biopsi hati untuk mendiagnosis fibrosis hati karena invasif membangkitkan penelitian metode noninvasif. Dilakukan penelitian uji diagnostik potong lintang untuk mengetahui akurasi rasio red cell distribution width (RDW) terhadap jumlah trombosit untuk memprediksi derajat fibrosis hati penderita hepatitis B kronik. Terhadap subjek penelitian dilakukan pemeriksaan HBsAg, darah rutin, dan fibroscan di RSUP H. Adam Malik, Medan sejak Januari sampai Maret 2015. Nilai rasio RDW terhadap trombosit dihitung dari hasil pemeriksaan darah rutin. Derajat fibrosis hati dinilai berdasarkan hasil fibroscan dari skala F0–F4. Prosedur analisis adalah receiver operating characteritic (ROC) dan area under the curve (AUC). Dari 34 kasus, 20 orang termasuk kelompok fibrosis hati ringan-sedang (F≤2) dan 14 orang kelompok fibrosis berat (F>2). Nilai akurasi sebesar 72,3% (IK 95%:84,1–97%). Dengan nilai cut-off 0,0591 didapatkan sensitivitas 71,4%; spesifisitas 60%; nilai prediksi positif (NPP) 55,6%; nilai prediksi negatif (NPN) 75%; rasio kemungkinan positif (RKP) 1,79; dan rasio kemungkinan negatif (RKN) 0,48. Simpulan, rasio RDW terhadap jumlah trombosit mampu memprediksi derajat fibrosis hati penderita hepatitis B kronik dengan tingkat akurasi sedang (72,3%).

 

DIAGNOSTIC ACCURACY OF LIVER FIBROSIS BASED ON RED CELL DISTRIBUTION WIDTH (RDW) TO PLATELET COUNT WITH FIBROSCAN IN CHRONIC B HEPATITIS

Chronic hepatitis B is a global problem and Indonesia has a high prevalence. Limitation of liver biopsy as an invasive method, initiates many studies on non invasive diagnosing method for liver fibrosis. The cross sectional study was conducted to determine the accuracy of red cell distribution width (RDW) to platelet count ratio (RPR) in predicting liver fibrosis degree in chronic hepatitis B. HBsAg, complete blood count, and fibroscan were examined in H. Adam Malik Hospital, Medan from January to March, 2015. RPR was calculated. The degree of liver fibrosis assessed by fibroscan on a scale of F0–F4. The accuracy was evaluated by constructing receiver operating characteritic (ROC) and area under the curve (AUC). From 34 cases, 20 subjects were in mild-moderate liver fibrosis (F≤2) and 14 subjects in severe liver fibrosis (F>2). The accuracy was 72.3% (95% CI: 84.1–97%) with a cut-off value 0.0591. Sensitivity was 71.4%, specificity 60%, positive predictive value (PPV) 55.6%, negative predictive value (NPV) 75%, positive predictive ratio (PPR) 1.79, and negative predictive ratio (NPR) was 0.48. RDW to platelet count ratio can predict liver fibrosis grade in chronic hepatitis B with a moderate degree of accuracy (72.3%).


Keywords


Chronic hepatitis B; fibroscan; fibrosis hati; hepatitis B kronik; liver fibrosis; platelet; RDW; trombosit

References


Badan Penelitian dan Pengembangan Kesehatan. Riset Kesehatan Dasar 2007. Jakarta: Departemen Kesehatan Republik Indonesia; 2008.

Pradella P, Bonetto S, Turchetto S, Uxa L, Comar C, Zorat F, dkk. Platelet production and destruction in liver cirrhosis. J Hepatol. 2011;54(5):894–900.

Grigorescu M. Non invasive biochemical markers of liver fibrosis. J Gastrointestin Liver Dis. 2006;15(2):149–59.

Lee KG, Seo YS, An H, Um SH, Jung ES, Keum B, dkk. Usefulness of non invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B. J Gastroenterol Hepatol. 2010;25(1):94–100.

Poynard T, Morra R, Ingiliz P, Imbert-Bismut F, Thabut D, Messous D, dkk. Assessment of liver fibrosis: noninvasive means. Saudi J Gastroenterol. 2008;14(4):163–73.

Kim SU, Han KH, Ahn SA. Transient elastography in chronic hepatitis B: an Asian perspective. World J Gastroenterol. 2010;16(41):5173–80.

Ledinghen VD, Vergniol J. Transient elastography (fibroscan). Gastroenterol Clin Biol. 2008;32:58–66.

Lou YF, Wang MY, Mao WL. Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS ONE. 2012;7(5):1–6.

Chen B, Ye B, Zhang J, Ying L, Chen Y. RDW to platelet ratio: a novel noninvasive index for predicting hepatic fibrosis and cirrhosis in chronic hepatitis B. PLoS ONE. 2013;8(7):e68780.

Koda M, Matunaga Y, Kawakami M, Kishimoto Y, Suou T, Murawaki Y. FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C. Hepatology. 2007;45(2):297–306.

Vallet PA, Mallet V, Pol S. FIB-4: a simple, inexpensive, and accurate marker of fibrosis in HCV-infected patients. Hepatology. 2006; 44:769–70.

Castera L. Non invasive methods to assess liver diseases in patients with hepatitis B or C. Gastroenterology. 2012; 142:1293–302.

Sembiring J. Correlation between thrombopoietin serum level and liver fibrosis in chronic hepatitis patients. Department of Internal Medicine, Faculty of Medicine University of North Sumatera/Adam Malik Hospital, Medan. Indon J Gastroenterol Hepatol Digestive Endoscopy. 2010;11:3.

Nwokediuko SC, Ibegbulam O. Quantitative platelet abnormalities in patients with hepatitis B virus-related liver diseases. Gastroenterol Res. 2009;2(6):344–9.

Xu WS, Qiu XM, Ou QS, Liu C, Lin JP, Chen HJ, dkk. Red blood cell distribution width levels correlate with liver fibrosis and inflammation: a non invasive serum marker panel to predict the severity of fibrosis and inflammation in patients with hepatitis B. Medicine (Baltimore). 2015;94(10):e612.

Huang R, Yang C, Wu K, Cao S, Liu Y, Su R, dkk. Red cell distribution width as a potential index to assess the severity of hepatitis B virus related liver diseases. Hepatol Res. 2014;44(14):E464–70.

Abdelmaksoud AHK, Taha MES, Kassas ME, Mahdy RE, Mohamed GDE, Samy HA. Prospective comparison of transient elastography and liver biopsy for the assessment of fibrosis in chronic hepatitis C infection. Egyptian J Radiol Nuclear Med. 2015;46:293–7.




DOI: https://doi.org/10.29313/gmhc.v4i2.1875

pISSN 2301-9123 | eISSN 2460-5441


Visitor since 19 October 2016: 


Free counters!


Global Medical and Health Communication is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.